Kerusso Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.36M Sell
12,382
-877
-7% -$313K 2.18% 12
2025
Q4
$4.34M Buy
13,259
+3,196
+32% +$1.01M 2.01% 20
2025
Q3
$2.84M Sell
10,063
-858
-8% -$249K 1.75% 31
2025
Q2
$3.05M Buy
10,921
+5
+0% +$1.42K 1.89% 26
2025
Q1
$3.4M Buy
10,916
+271
+3% +$80K 2.16% 17
2024
Q4
$2.77M Buy
10,645
+23
+0.2% +$6.82K 1.77% 26
2024
Q3
$3.42M Buy
10,622
+628
+6% +$205K 2.17% 12
2024
Q2
$3.12M Buy
+9,994
New +$2.94M 2.27% 13

Other funds holding AMGN

Kerusso Capital Management's AMGN Position: Q1 2026 in Review

Kerusso Capital Management reduced its Amgen (AMGN) stake by 6.6% in Q1 2026, selling an estimated $313K and leaving 12,382 shares worth $4.36M. The position accounts for 2.18% of the portfolio, ranked #12.

Kerusso Capital Management first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kerusso Capital Management held 12,382 shares of Amgen worth $4.36M as of Q1 2026.
  • Kerusso Capital Management sold 877 Amgen shares in Q1 2026, an estimated $313K.
  • Amgen made up 2.18% of Kerusso Capital Management's portfolio in Q1 2026, its #12 holding.
  • Kerusso Capital Management first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kerusso Capital Management's 13F filing for Q1 2026, filed 14 May 2026.